Andra AP-fonden’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.43M Sell
89,487
-285,913
-76% -$22M 0.08% 256
2025
Q4
$29.8M Buy
375,400
+4,600
+1% +$363K 0.37% 74
2025
Q3
$28M Buy
+370,800
New +$25.4M 0.36% 95
2024
Q4
Sell
-145,700
Closed -$9.16M 407
2024
Q3
$9.16M Sell
145,700
-73,400
-34% -$4.28M 0.13% 232
2024
Q2
$12.9M Sell
219,100
-29,200
-12% -$1.83M 0.22% 159
2024
Q1
$19.8M Buy
+248,300
New +$19M 0.35% 91
2023
Q3
Sell
-167,200
Closed -$11.6M 339
2023
Q2
$11.6M Buy
167,200
+37,700
+29% +$2.68M 0.29% 61
2023
Q1
$9.62M Buy
129,500
+35,000
+37% +$2.93M 0.25% 129
2022
Q4
$8.81M Sell
94,500
-33,300
-26% -$3.21M 0.27% 98
2022
Q3
$12.2M Sell
127,800
-36,400
-22% -$3.6M 0.4% 24
2022
Q2
$15.2M Buy
+164,200
New +$16M 0.44% 10
2021
Q4
$19.9M Buy
193,300
+16,500
+9% +$1.52M 0.41% 13
2021
Q3
$15M Buy
176,800
+8,100
+5% +$678K 0.31% 47
2021
Q2
$14.1M Buy
168,700
+3,200
+2% +$262K 0.29% 63
2021
Q1
$12.5M Buy
165,500
+17,700
+12% +$1.29M 0.27% 68
2020
Q4
$10.1M Buy
147,800
+83,900
+131% +$5.46M 0.22% 140
2020
Q3
$3.73M Sell
63,900
-29,500
-32% -$1.84M 0.1% 468
2020
Q2
$6.07M Buy
93,400
+15,800
+20% +$995K 0.18% 229
2020
Q1
$4.6M Buy
77,600
+11,100
+17% +$741K 0.17% 252
2019
Q4
$4.94M Sell
66,500
-11,500
-15% -$807K 0.14% 386
2019
Q3
$4.92M Sell
78,000
-5,400
-6% -$320K 0.15% 362
2019
Q2
$4.54M Buy
83,400
+6,700
+9% +$361K 0.13% 421
2019
Q1
$4.14M Buy
+76,700
New +$4.73M 0.12% 452
2018
Q3
$7.38M Sell
93,800
-2,300
-2% -$164K 0.19% 193
2018
Q2
$6.18M Sell
96,100
-21,300
-18% -$1.4M 0.17% 277
2018
Q1
$7.3M Sell
117,400
-13,048
-10% -$936K 0.19% 186
2017
Q4
$9.46M Buy
130,448
+11,848
+10% +$861K 0.21% 131
2017
Q3
$9.64M Buy
118,600
+11,100
+10% +$878K 0.23% 126
2017
Q2
$8.65M Sell
107,500
-4,400
-4% -$347K 0.21% 131
2017
Q1
$8.78K Sell
111,900
-1,100
-1% -$87.8K 0.21% 127
2016
Q4
$8.92M Buy
113,000
+15,200
+16% +$1.23M 0.24% 110
2016
Q3
$8.7M Sell
97,800
-21,099
-18% -$1.99M 0.23% 123
2016
Q2
$11.4M Sell
118,899
-2,300
-2% -$229K 0.29% 90
2016
Q1
$12.6M Sell
121,199
-15,201
-11% -$1.48M 0.33% 76
2015
Q4
$13.3M Sell
136,400
-12,000
-8% -$1.18M 0.38% 64
2015
Q3
$14.3M Buy
148,400
+5,800
+4% +$610K 0.42% 54
2015
Q2
$15M Buy
142,600
+47,200
+49% +$4.82M 0.43% 48
2015
Q1
$9.85M Sell
95,400
-17,600
-16% -$1.78M 0.28% 92
2014
Q4
$10.9M Buy
113,000
+7,800
+7% +$687K 0.25% 106
2014
Q3
$8.37M Sell
105,200
-67,500
-39% -$5.32M 0.2% 161
2014
Q2
$13M Sell
172,700
-93,000
-35% -$7.03M 0.29% 98
2014
Q1
$19.9M Sell
265,700
-4,600
-2% -$325K 0.46% 42
2013
Q4
$19.3M Sell
270,300
-29,500
-10% -$1.9M 0.46% 40
2013
Q3
$17M Buy
299,800
+2,700
+0.9% +$161K 0.43% 44
2013
Q2
$17M Buy
+297,100
New +$17.2M 0.44% 38

Other funds holding CVS

Andra AP-fonden's CVS Position: Q1 2026 in Review

Andra AP-fonden reduced its CVS Health (CVS) stake by 76% in Q1 2026, selling an estimated $22M and leaving 89,487 shares worth $6.43M. The position accounts for 0.08% of the portfolio, ranked #256.

Andra AP-fonden first reported a position in CVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $29.8M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Andra AP-fonden held 89,487 shares of CVS Health worth $6.43M as of Q1 2026.
  • Andra AP-fonden sold 285,913 CVS Health shares in Q1 2026, an estimated $22M.
  • CVS Health made up 0.08% of Andra AP-fonden's portfolio in Q1 2026, its #256 holding.
  • Andra AP-fonden first reported a position in CVS Health in Q2 2013 and has held it in 45 quarters since.
  • Andra AP-fonden's CVS Health position peaked at $29.8M in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.